About the Global Campaign

In countries from the U.S. to Vietnam, Brazil to Indonesia, health groups are aiming to break Abbott’s monopoly control over lopinavir+ritonavir (Kaletra). Campaigners say Abbott’s high price for Kaletra is blocking expansion of AIDS treatment, and its anti-competitive practices are impeding new drug innovation.

Kaletra campaign flyer


Press Release (November 9, 2011)

English | Español | Chinese

Access Story Spotlight

"I wish the drug company would lower the price, as I know that the number of people taking Kaletra is growing higher and higher – and there are many more who can’t afford the treatment they need." --Naza of Malaysia's PT Foundation


Secondary Patenting: A Threat to Affordable Generic Patenting by I-MAK

Read about how Abbott is seeking to artificially extend its patents on lopinavir+ritonavir

Read full article here

 

Information About Ritonavir (Kaletra Component)

English | Español

 

Kaletra - Abbott's Abusive Practices

 

Information About Abbott Laboratories

 

Campaign Actions FAQ (Compulsory Licensing, Patent Opposition, March-In Request, Voluntary Licensing)

English | Español

 

TRIPS & Public Health FAQ - World Trade Organization

English | Español

 





Return to the Kaletra Campaign Homepage


Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.